Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:119-124
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garratt, K. N.
Right arrow Articles by Holmes, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garratt, K. N.
Right arrow Articles by Holmes, D. R., Jr.

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction

Kirk N. Garratt, MD, FACCa, Peter A. Brady, MD, MRCPa, Nancy L. Hassinger, MDa, Diane E. Grilla, Andre Terzic, MD, PhDa and David R. Holmes, Jr., MD, FACCa

a Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, USA



View larger version (10K):

[in a new window]
 
Figure 1 Multivariate correlates of in-hospital mortality (odds ratios and 95% confidence intervals).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement